Alector (ALEC)
(Delayed Data from NSDQ)
$6.49 USD
0.00 (0.00%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $6.49 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ALEC 6.49 0.00(0.00%)
Will ALEC be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ALEC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ALEC
Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates
ALEC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Alector (ALEC) Report Negative Q1 Earnings? What You Should Know
Earnings Preview: Alector (ALEC) Q4 Earnings Expected to Decline
Strength Seen in Alector (ALEC): Can Its 6.0% Jump Turn into More Strength?
Other News for ALEC
Catalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earnings
Commit To Buy Alector At $5, Earn 43.3% Annualized Using Options
Goldman Sachs Keeps Their Sell Rating on Alector (ALEC)
Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference? (AAIC?) 2024
Analysts’ Top Healthcare Picks: Amneal Pharmaceuticals (AMRX), Alector (ALEC)